• Research
    • Research groups
    • Functional Genomics Area
    • Strategic Line 1: The Human Genome
    • Strategic Line 2: Cancer Genomics
    • Personalised Medicine Area
    • Strategic Line 3: Detection, Diagnostics, Monitoring and Prognostics of Diseases
    • Strategic Line 4: Advanced Therapies
    • Publications
    • International Projects

There are no projects in the garbage can.

  • WebMail
  • Private area
  • Español
  • Center
    • What is GENyO?
    • Support Units
    • Management Units
    • Strategic Plan 2024-2027
    • Transparency
    • Contact
  • Events and news
    • News
    • Events
    • Scientific Conferences
    • Galleries
  • GENyO TV
  • Research
    • Research groups
    • Functional Genomics Area
    • Strategic Line 1: The Human Genome
    • Strategic Line 2: Cancer Genomics
    • Personalised Medicine Area
    • Strategic Line 3: Detection, Diagnostics, Monitoring and Prognostics of Diseases
    • Strategic Line 4: Advanced Therapies
    • Publications
    • International Projects
  • Center
    • What is GENyO?
    • Support Units
    • Management Units
    • Strategic Plan 2024-2027
    • Transparency
    • Contact
  • Events and news
    • News
    • Events
    • Scientific Conferences
    • Galleries
  • GENyO TV
  • WebMail
  • Private area
  • Español

There are no projects in the garbage can.

International Projects

diaRNAgnosis

Home

diaRNAgnosis

diaRNAgnosis

GenE-Humdi – Genome Editing for the treatment of human Disease Network

GenE-Humdi – Genome Editing for the treatment of human Disease Network

Program SPARK THERAPUTICS INC

Program SPARK THERAPUTICS INC

3TR

3TR

Research

Publications

See more

International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors.

Authors: Fusco N, Venetis K, Pepe F, Shetty O, Farinas SC, Heeke S, Burnier JV, Patton SJ, Heitzer E, Nigita G, Hofman P, Serrano MJ, Cristofanilli M, Jantus-Lewintre E, Gandara DR, Rolfo C, Malapelle U

05/2025 - The journal of liquid biopsy

Integration of T cell repertoire, CyTOF, genotyping and symptomatology data reveals subphenotypic variability in COVID-19 patients.

Authors: Marín-Benesiu F, Chica-Redecillas L, Cuenca-López S, Entrala-Bernal C, Martín-Esteban S, Alvarez-Cubero MJ, Martínez-González LJ

05/2025 - Computational and structural biotechnology journal

Cross-talk between NLRP3 and AIM2 inflammasomes in macrophage activation by LPS and titanium ions.

Authors: Carrillo-Gálvez AB, Guerra-Valverde JA, Padial-Molina M, Martínez-Cuevas A, Abril-García D, Olaechea A, Martín-Morales N, O'Valle F, Galindo-Moreno P, Zurita F

06/2025 - Molecular medicine (Cambridge, Mass.)

    Transparency

  • Documents of interest
  • Organizational structure
  • Organizational chart

    Research

  • Research groups
  • Functional Genomics Area
  • Personalised Medicine Area
  • International Projects
  • Publications

    Center

  • What is GENyO?
  • Support Units
  • Management Units
  • Strategic Plan 2024-2027
  • Transparency
  • Contact

    Events and news

  • News
  • Events
  • Scientific Conferences
  • Galleries

Address

Avda. de la Ilustración 114.
18016 Granada, Spain

+34 958 715 500
info@genyo.es
  • Company affiliation

    2025 @Genyo All rights reserved

  • Legal note
  • Cookies Policy
  • Privacy Policy